An infant who received haploidentical BM for severe combined immunodeficiency (SCID) developed acute, reversible complete heart block in association with an exacerbation of GVHD. Respiratory distress and myocardial dysfunction were also seen with this and previous GVHD exacerbations. The patient had not received chemotherapy or radiation prior to BMT. The complete heart block resolved after 1 week of intensive immunosuppression. The association of complete heart block with GVHD is important because the heart block is potentially reversible with prompt, aggressive control of the GVHD. Keywords: cardiac; heart block; arrhythmia; graftversus-host disease; bone marrow transplantation Graft-versus-host disease is a major cause of morbidity and mortality after bone marrow transplantation. GVHD manifestations are predominantly limited to the skin, gastrointestinal tract, and liver.
Graft-versus-host disease is a major cause of morbidity and mortality after bone marrow transplantation. GVHD manifestations are predominantly limited to the skin, gastrointestinal tract, and liver. 1 However, severe GVHD is associated with a marked release of cytokines ('cytokine storm') 2 that may result in more widespread organ involvement. Cardiac involvement during acute or chronic GVHD has been reported to be infrequent, mild and generally asymptomatic. 3, 4 We report the second case of complete atrioventricular block occurring in association with GVHD. A case of complete heart block has been reported in a patient with SCID who received an haploidentical parental marrow transplant. The patient had acute GVHD of the skin, liver and gut which was treated with high-dose steroids and monoclonal antibody. He had recurrent symptoms and signs of chronic GVHD and was maintained on low-dose steroids. Skin and liver biopsies were consistent with chronic GVHD. The patient developed complete heart block at day +97 and required a pacemaker. A myocardial biopsy showed interstitial edema, focal mononuclear cell infiltrate, and individual fiber degeneration. The lymphohistiocytic infiltrate resembled that from the skin biopsy. The patient Correspondence: Dr A Gilman, Pediatric Hematology/Oncology, The Children's Mercy Hospital, 2401 Gillham Road, Kansas City, MO 64108, USA Received 14 March 1997; accepted 14 July 1997 died 1 month later and autopsy results showed similar infiltrates with foci of necrosis and scarring present in the atrioventricular node, bundle of His and myocardium. No evidence of viral infection was found on the premortem biopsy specimen or at autopsy. 5 The patient in our report was treated with intensive immunosuppression, had reversal of his complete heart block, and remains well.
Case report
The patient was diagnosed with SCID when he presented at 4 months of age with Pneumocystis carinii pneumonia and failure to thrive. He had severe pneumonia and required a high-frequency ventilator and nitric oxide for 2 weeks. He had no clinical evidence of cardiac dysfunction.
Immunophenotyping showed a lack of T lymphocytes and NK cells, and the presence of B lymphocytes. He received haploidentical T cell-depleted bone marrow from his father. T cell depletion was performed with OKT3 antibody and rabbit complement, which resulted in уtwo log depletion of T cells. He received no preparative therapy and no systemic GVHD prophylaxis.
On day +8 after transplant, he developed fever, tachypnea, tachycardia and irritability. He had no rash and only a brief period of liquid diarrhea. Within hours, he had respiratory failure and required intubation. A chest X-ray showed diffuse pulmonary infiltrates bilaterally. He was started on vancomycin, ceftazidime, gentamicin, high-dose bactrim, amphotericin and ganciclovir as empiric therapy for infection. Bronchoalveolar lavage was negative for bacterial, viral, fungal, and protozoal pathogens. He rapidly deteriorated and required a high-frequency ventilator and nitric oxide. He also had decreased cardiac output and required dobutamine and amrinone. He was started on methylprednisolone (MP) 2 mg/kg/day for possible immune-mediated lung disease. On day +11, he developed a blotchy erythematous maculopapular rash on his trunk, arms and groin. A skin biopsy showed a sparse lymphoid perivascular infiltrate and scattered eosinophils in the papillary dermis. Necrotic keratinocytes were not seen and the rash was considered to be drug-related. The rash progressed to cover most of the body by day +14. Coincidentally, the patient's absolute lymphocyte count (ALC) rose from 0 on day +9 to 21775 on day +14 and was accompanied by a marked eosinophilia (Figure 1) . Immunophenotyping of the patient's peripheral blood mononuclear cells showed 91% CD3 + cells (98% expressing the activation marker CD38) with 69% CD4 + and 16% CD8 + . HLA typing showed these lymphocytes to be of paternal origin.
The patient received MP 10 mg/kg on day +14 and 5 mg/kg on the next 3 days. Of note, he had transient episodes of bradycardia with junctional rhythm on day +16. He had gradual improvement in his rash and was weaned off inotropic support. Cyclosporine (CYA) was started on day +18 to provide additional immunosuppression during tapering of the high-dose steroids. His lung function initially improved but then plateaued. He had positive blood cultures for S. epidermidis on days +18, 19 and 24 and for S. aureus on day +19. Because of his infections and the lack of GVHD on skin biopsy, CYA was discontinued on day +22 and MP was rapidly weaned to 1 mg/kg/day. The patient was extubated on day +24. On day +27, the patient developed a mild erythematous rash and fever. The next day, he had voluminous diarrhea and was given a total of 6 mg/kg of MP. Over the next few days, the rash progressed to a degree consistent with stage III GVHD and the diarrhea became bloody. CYA was restarted. A rectal biopsy showed apoptosis and severe crypt destruction consistent with severe GI GVHD. Over the next several days, the patient improved on CYA and MP 3 mg/kg/day. He did well for 2 weeks and his MP was slowly weaned to 2 mg/kg/day. On day +63, graft rejection was suspected based on routine HLA typing for donor chimerism. Preliminary HLA typing showed only host cells. CYA was discontinued and MP was decreased to 1 mg/kg/day. Three days later, the patient had an erythematous rash, fever, emesis and mild respiratory distress. His MP was increased to 2 mg/kg/day. Further evaluation of HLA typing showed that B lymphocytes were of host origin, but that T lymphocytes were of donor origin. Over the next 2 days, he had a progressive rash, an increase in emesis and stool output, and persistent low-grade fevers. His MP was increased to 4 mg/kg/day on day +70. His symptoms progressed and CYA was restarted on day +71. On day +72, he developed intermittent second degree heart block, which rapidly progressed to complete atrioventricular block with a wide QRS complex. The patient had several episodes of asystole. Epinephrine and isoproterenol were required to maintain an adequate ventricular rate. His shortening fraction was 40% by echocardiogram (on these inotropic drugs) and his creatine kinase was normal. He received MP 7 mg/kg/day on day +72 and 6 mg/kg/day on day +73. He was also started on vancomycin, ceftazidime, and gentamicin because of fever. On day +74, he had a transvenous pacing catheter placed. He was intubated for the catheter placement and remained intubated for heavy sedation to prevent dislodgement of the pacer wires. The epinephrine and isuprel were discontinued, but he required dobutamine for adequate cardiac output for several more days. His rash and diarrhea resolved. He had a sinus rhythm intermittently on day +78 and was in normal sinus rhythm on day +79. Multiple cultures for CMV, adenovirus, and other viruses were negative. The patient never had recurrence of arrhythmias or GVHD and he is now off immunosuppression. He is doing well more than 18 months after BMT.
Discussion
This patient experienced respiratory distress, myocardial dysfunction, and complete heart block in association with exacerbations of GVHD. He had atypical hyperacute GVHD with a rapid increase in lymphocyte count and cardiorespiratory findings out of proportion to other clinical manifestations of GVHD. Subsequent exacerbations of GVHD occurred each time his immunosuppression was weaned. The cardiorespiratory problems could have resulted directly from cytokine-related damage, lymphocytic infiltration, or the recruitment of other effectors such as neutrophils or macrophages. The relatively rapid reversal of the complete heart block after intensive immunosuppression supports an immune etiology.
Other potential etiologies of our patient's heart block include viral myocarditis, myocardial ischemia secondary to coronary artery obstruction by fungus, 6 and drug-induced arrhythmias. The similarity of the GVHD exacerbations, including arrhythmias with the initial episode and the episode associated with complete heart block, supports an association between GVHD and the complete heart block. No viral etiology was detected and no evidence of myocardial ischemia was present. The patient was not receiving drugs commonly associated with bradyarrhythmias. Bradycardia and complete heart block have been reported in association with very high-dose MP. 7 However, the resolution of our patient's bradyarrhythmias despite similar doses of MP argue against this potential cause.
Complete heart block has been described in association with toxic shock syndrome. 8 This syndrome shares an intense immune response and a marked release of cytokines with GVHD. The authors noted that pathological findings in toxic shock syndrome include lymphocytic infiltration of the myocardium and vacuolar cellular degeneration of myocardial cells. 9 They suggested that tumor necrosis factor (TNF) may have caused the reversible heart block seen in their patient since TNF impairs muscle electrical activity. 10 TNF also decreases myocardial contractility.
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Although tachyarrhythmias are more common, bradyarrhythmias and complete heart block have also been described in association with the therapeutic use of interleukin-2. 12 A marked increase in IL-2 production would be predicted to have accompanied the rise in the lymphocyte count seen with the exacerbations of GVHD. A concomitant rise in the eosinophil count has been seen with the therapeutic use of IL-2 13 and may result from increased production of other cytokines such as IL-5 as a result of T cell activation.
Cytokine overproduction is currently believed to play a major role in the pathogenesis and manifestations of GVHD. Increases in IL-2, TNF, IL-1, IL-6 and ␥-interferon have been correlated with GVHD.
14 High levels of TNF and IL-2 were likely related to this patient's cardiorespiratory complications, either directly or through secondary mediators. The atypical features seen in this patient may reflect an unusually high production of cytokines (similar to that seen in toxic shock syndrome) or may be due to a relative lack of secondary effector cells. The number of NK cells present was very low, reflecting the patient's underlying immunodeficiency. Several studies have suggested that recipient NK cells are important mediators of tissue damage in acute GVHD. 15 Although damage to the cardiac conduction system is likely to be an uncommon sequelae of GVHD, the association is important. Our patient's severe cardiac arrhythmia was reversible with aggressive immunosuppression. Conduction abnormalities due to viral myocarditis may similarly be reversed after several days of immunosuppression. The potential reversibility should prompt caution in placing a permanent pacemaker and in making 'salvagability' decisions. Although myocardial infarction, including those secondary to obstruction of the coronary arteries by fungus, viral myocarditis, and drug-induced arrhythmias are likely more common causes of heart block in BMT patients, a relationship with GVHD should be considered.
